David Owens Nexalin Technology, Inc. (NXL) insider trading activity

NXL Quotes by TradingView

David Owens is Chief Medical Officer of Nexalin Technology, Inc.. Currently has a direct ownership of 148,293 shares of NXL, which is worth approximately $434,498. The most recent transaction as insider was on Oct 28, 2024, when has been sold 500 shares (Common Stock) at a price of $2.19 per share, resulting in proceeds of $1,095. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 148K
1.02% 3M change
5.04% 12M change
Total Value Held $434,498

David Owens Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 28 2024
BUY
Open market or private purchase
$1,095 $2.19 p/Share
500 Added 0.34%
148,293 Common Stock
Aug 13 2024
BUY
Open market or private purchase
$950 $0.95 p/Share
1,000 Added 0.67%
147,793 Common Stock
Jun 28 2024
BUY
Open market or private purchase
$1,750 $1.75 p/Share
1,000 Added 0.68%
146,793 Common Stock
Jun 18 2024
BUY
Open market or private purchase
$1,149 $0.71 p/Share
1,619 Added 1.1%
145,793 Common Stock
Jun 10 2024
BUY
Open market or private purchase
$1,920 $0.64 p/Share
3,000 Added 2.04%
144,174 Common Stock
Sep 16 2022
BUY
Open market or private purchase
$10,375 $4.15 p/Share
2,500 Added 1.74%
141,174 Common Stock
DO

David Owens

Chief Medical Officer
Atlanta, GA

Track Institutional and Insider Activities on NXL

Follow Nexalin Technology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NXL shares.

Notify only if

Insider Trading

Get notified when an Nexalin Technology, Inc. insider buys or sells NXL shares.

Notify only if

News

Receive news related to Nexalin Technology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NXL